Boston Scientific’s innovative products designed for use by Oncologists may provide options for cancer patients who require less invasive treatments.
RF 3000® Radiofrequency Ablation System and RF Needle Electrode Families are intended for the thermal coagulation necrosis of soft tissues, including partial or complete ablation of nonresectable liver lesions. The RF3000 Radiofrequency Ablation System is an impedance-based feedback system. LeVeen® Needle Electrodes are designed for open, laparoscopic or percutaneous radiofrequency ablation, providing a cannula and a patented array design that is available in a choice of diameters. The Soloist™ Single Needle Electrode is designed for the treatment of small, difficult-to-access lesions. Caution: The effectiveness of these devices for the use in the treatment of liver cancer or liver disease (i.e., improved clinical outcomes) has not been established.
Renegade® Hi-Flo Microcatheter
Setting the Standard of Performance in .027" I.D. microcatheters, the Renegade Hi-Flo Microcatheter is designed for distal access and exceptional flow. Its .027" inner lumen is designed to provide high flow delivery of viscous embolic materials, therapeutic agents and increased infusion pressures, further enhancing flow.
Fathom™ Steerable Guidewire
The Fathom Steerable Guidewire combines a nitinol hypotube distal segment with advanced microfabrication technology, creating a design to allow access to tortuous vasculature. Unlike conventional guidewires, the nitinol hypotube distal segment is designed to transmit turn-for-turn torque to enhance responsiveness and maneuverability.
American Cancer Society is a registered trademark of the American Cancer Society.
National Cancer Institute is a registered trademark of the National Cancer Institute Agency.
